Skip to content
Insider tapeFilings through Fri, Oct 9
Watchlist

Timothy C Barabe

Director at Cartesian Therapeutics, Inc. (RNAC)

Purchase track record

Not enough history. Based on 1 purchase with a full 90 days of price history.

—
Avg. 90-day return+34.2%
vs. S&P 500+34.7%
Beat the market100%
Paper profit on buys+$6K
Total bought / sold$206K / $0

Reported trades

Filed Stock Type Shares Price Value Since
Dec 8SEC RNACCartesian Therapeutics, Inc. Buy 30,00054,366 held (+123%) $6.86 $206K +2.8%
  • Buy

    Director Timothy C Barabe bought $206K of RNAC at $6.86 — first open-market purchase in our records; raises the stake by 123%.